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Summary Previous studies have suggested that 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-
3-nitrosoureahydrochloride (ACNU) and 1,(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) bind
specifically to the nucleosomal DNA of murine bone marrow and L1210 leukaemia cells whereas the glucose
nitrosoureas, 2-(3-(2-chloroethyl)-3-nitrosoureido)-2-deoxy-D-glucopyranose, (chlorozotocin, CLZ) and 1-(2-
chloroethyl)-3-(-D-glucopyranosyl)-l-nitrosourea (GANU), bind preferentially to the linker DNA of bone
marrow but not tumour cell chromatin. In order to provide an explanation for this differential, the DNA
repeat and linker lengths in murine bone marrow and L1210 leukaemia cells were measured using
electrophoresis of micrococcal nuclease-digested DNA. The linker length of bone marrow chromatin was
approximately 22% longer than that in L1210 leukaemia cells from mouse ascites. The linker length of L1210
cells maintained in suspension culture was 27% less than in those from ascites fluid. The tissue-specific
toxicity of sugar nitrosoureas and the differential binding of these drugs to chromatin does not appear to
correlate quantitatively with differences in DNA linker length.
The use of nitrosoureas in cancer chemotherapy has
been seriously limited by their acute myelotoxicity,
(Wasserman et al., 1975; Osband et al., 1977). This
problem led to the development of the glucose-
nitrosourea analogues, 2-(3-(2-chloroethyl)-3-nitro-
soureido)-2-deoxy-D-glucopyranose, (chlorozotocin,
CLZ) and 1-(2-chloroethyl)-3-(-D-glucopyranosyl)-
1-nitrosourea (GANU) which were less myelotoxic
than the more traditional chloroethylnitrosoureas,
1,(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)
and 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-
(2-chloroethyl)-3-nitrosoureahydrochloride (ACNU)
yet retained comparable antitumour activity in
experimental tumours as well as in man (Panasci et
al., 1977, 1979; Hoth et al., 1980). Myelosuppression
was not correlated with the more usual explanations
of alkylating or carbamoylating potential, cellular
drug uptake, type of DNA lesion or DNA repair
(Vu et al., 1983). Efforts to determine why the
glucose-nitrosoureas were less toxic to bone marrow
have considered the binding of drugs to chromatin
and chromatin constituents. The nucleosomal core
of chromatin consists of histones H2A, H2B, H3
and H4 in the form of a double tetramer (Thomas
& Kornberg, 1975) which is highly conserved for
many generations during cell proliferation (Gurley &
Hardin, 1969; Hancock, 1969) and around which is
wound DNA (Thomas & Kornberg, 1975; Worcel &
Benyajati, 1977) some 146bp in length (Noll &
Kornberg, 1977). The nucleosomes are connected
by linker DNA which can vary in length from 20bp
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in fungi to lOObp in sea-urchin sperm (Chambon,
1977). Histone Hi is often, but not always, present
and is thought to stabilize the helical winding of
DNA around the core proteins, with additional
involvement of non-histone proteins (Noll &
Kornberg, 1977). This repeating nucleosomal struc-
ture is found in both transcriptionally active and
inactive chromatin (Felsenfeld, 1978) although the
active regions have been shown to be enriched in
non-histone proteins (Gottesfeld & Butler, 1977).
Using radiolabelled drugs, it was found that both
GANU and CLZ alkylated the DNA of L1210
leukaemia cells more than that of mouse bone
marrow, whereas ACNU and CCNU both preferen-
tially alkylated the DNA of bone marrow (Tew
et al., 1978; Green et al., 1982). Through the use
of transcription-promoting agents, such as hydro-
cortisone, it was discovered that both CLZ and
CCNUboundpreferentiallytotranscriptionallyactive
chromatin (Tew et al., 1980). However, it was
necessary to consider a lower order of chromatin
organization before differences in binding between
myelotoxic and marrow-sparing nitrosoureas began
to emerge. Using micrococcal nuclease digestion
(Sollner Webb et al., 1978) and DNAse 1 digestion
(Billing & Bonner, 1972), studies using HeLa cells
showed that both CLZ and CCNU preferentially
alkylated the DNA associated with the core particle
(Tew et al., 1978). It was later shown that ACNU,
CCNU, CLZ and GANU all preferentially alkylated
the nucleosomal core DNA ofchromatin from in vivo
L1210 cells (Green et al., 1982). ACNU and CCNU
were more specific for the nucleosomal DNA of
mouse bone marrow but the glucose nitrosoureas,
CLZ and GANU, bound preferentially to the linker
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DNA of bone marrow chromatin. The reduced
myelotoxicity of the sugar nitrosoureas could be
explained if drug interaction with linker DNA were
less cytotoxic. Indeed, there are several reports that
the linker region of mammalian cell chromatin is
repaired preferentially after both alkylation and
UV-induced damage (Bodell, 1977; Cleaver, 1977;
Smerdon et al., 1979). This tissue specificity could
be due to differences in either the nature or
accessibility of the chromatin in the two cell types,
or, more simply, differences in the amount of linker
DNA available for drug interaction. In this paper
we have attempted to explain the increased binding
of sugar nitrosoureas to the linker DNA of mouse
bone marrow (Green et al., 1982) in terms of a
correspondingly increased length of linker DNA.
This would provide an explanation of the selective
toxicity in terms of a greater proportion of linker
versus nucleosomal DNA available for drug
interaction. We report measurements of the DNA
repeat and linker lengths in chromatin from murine
bone marrow and L1210 leukaemia cells. We have
observed small differences in linker length, though
insufficient to account entirely for the previously
reported differences in drug binding (Green et al.,
1982). Furthermore, although the nitrosoureas
tested had little effect on the fidelity of the micro-
coccal nuclease digestion assay, nitrogen mustard
did cause a marked alteration in the enzyme
digestion pattern.
Materials and methods
Cell cultures
L1210 mouse leukaemia cells were grown as
suspension cultures in RPMI 1640 (M.A.
Bioproducts, Walkerville, MD) supplemented with
100 Uml-1 penicillin, 100jugml- streptomycin,
4mM L-glutamine (all from M.A. Bioproducts,
Walkerville, MD) and 10% fetal calf serum (K.C.
Biologicals, Lenexa, KS). L1210 cells were main-
tained in vivo by serial passage in CDF1 mice and
obtained for experimentation by aspiration from
ascites fluid 7 days after i.p. innoculation with 105
cells. Bone marrow cells were obtained by
expression with medium from femurs and tibias
from normal CDF1 mice.
Drug treatment
Cultured L1210 cells were suspended at 107 ml- 1 in
whole medium and incubated in the presence of
drug before isolation of nuclei. CCNU, CLZ,
L-phenylalanine mustard (L-PAM) and nitrogen
mustard (HN2) were supplied by Dr V.L.
Narayanan, National Cancer Institute, Bethesda,
MD.
Isolation ofnuclei
All solutions were refrigerated and procedures
carried out at 4°C. Between 5 x 107 and 2 x 108
cells were used for each isolation. Cells were
washed twice with 15ml cold medium and
centrifuged at 3,500r.p.m. for 5min. Cells were
allowed to swell for 30min in 15ml RSB pH7.4
(1OmM TrisHCI, lOmM NaCl, 1.5mM MgCl2,
0.2mM PMSF), homogenized using 25 strokes of a
tight dounce, centrifuged for 5min at 3000r.p.m.,
resuspended in 15ml solution 3, pH6.8 (0.32M
sucrose, 0.3% Triton, 1 mM MgCl2, 0.2mMPMSF,
1mM K2HPO4) and further homogenized with 25
strokes of a loose dounce. The crude nuclei were
washed three times with solution 3 then twice with
solution 1, pH6.8 (0.32M sucrose, 2mM MgCl2,
1mMKH2PO4, 0.2mMPMSF). At each stage
nuclei were evenly suspended by careful aspiration
using a pasteur pipette and checked for con-
taminating cell debris by microscopic examination.
The final nuclear pellet was resuspended in 1 ml
buffer A, pH 7.4 (0.34 M sucrose, 15 mM TrisHCl,
60mM KCl, 15mM 2-mercaptoethanol, 0.15mM
spermidine, 1 mM CaCl2 at an A260 of 20, read in
0.1 MNaOH.
Enzyme digestion
Nuclei were incubated for 2min at 37°C prior to
digestion with 0.02Uml-1 micrococcal nuclease
(Sigma Chemical Co., St Louis, Mo.) for 1 min.
Enzyme activity was halted by addition of an equal
volume of cold 2mM EDTA. Nuclei were pelleted
by centrifugation at 6,000r.p.m. for 5min then
lysed on ice in 1 ml of 1 mM EDTA for 30min.
Chromatin was precipitated overnight at -20°C
after addition of 4vol of cold (-20°C) absolute
ethanol. Chromatin was pelleted by centrifugation
at 12,000r.p.m. for 10min and suspended in 1ml
lOmM Tris/lOmMNaCl, pH7.0 then incubated at
37°C for I h in the presence of 100jgmlP-1 RNAse
(Sigma) and for a further 3h in the presence of
50jgml-1 Proteinase K (Boehringer Mannheim,
W. Germany). Suspensions were made 1% in SDS
and 1 M in NaCl prior to extracting DNA 3 times
with 1 ml of phenol:chloroform:isoamyl alcohol
(24:24:1). The resulting DNA solution was added
to 4ml cold ethanol for overnight precipitation of
DNA at 20'C.
Gel electrophoresis
Polyacrylamide (2.5%)/agarose (0.5%) gels were
prepared as follows. Five millilitres of 19% acryla-
mide/1% N-N'-methylene bisacrylamide (Eastman
Kodak Co., Rochester, NY) in water, 4ml glycerol,
I ml 20 x concentrated running buffer (48.4g Tris
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distilled water, adjusted to pH 7.6 with glacial acetic
acid), 9ml distilled water and 12.5plNNN'N'-
tetramethylethylenediamine (Bio Rad Laboratories,
Richmond, CA) were mixed thoroughly and warmed
to 45°C. To this were added 20ml 1% agarose (Beth-
esda Research Laboratories, Gaithersburg, MD)
in running buffer at 45°C and 1 ml 4% ammonium
persulphate (Bio Rad) added immediately prior to
pouringthegel. DNAsamples werewashed twicewith
cold ethanol and dissolved in 10-20.ul 10mM Tris/
1 mM EDTA, pH 7.2. The DNA solutions were
mixed with an equal volume of saturated sucrose
solution containing 0.001% bromophenol blue
(Eastman Kodak) and run alongside OX174 HaeIII
restriction fragments (BRL, MD) as marker DNA.
Gels were run for 3h at room temperature.
Electrophoresis overnight or in the cold did not alter
resolution.
Gels were stained by immersion in 5jugml-
ethidium bromide (Sigma) for 15min, followed by a
water wash for 15min. DNA fluorescence was
visualized using a 305nm UV-light box, then
photographed with a Polaroid instant camera.
Photographs were scanned using a Quick Scan Jr.
scanning densitometer (Helena Labs., Beaumont,
TX) and migration of bands measured on the
resultant traces. For each gel, calibration curves
based on marker DNA migration were constructed
and used to calculate the numbers of base pairs in
the sample DNA bands.
Results
Figure 1 is an example of a gel on which DNA
fragments from micrococcal nuclease-digested nuclei
isolated from L1210 leukaemia (cultured and mouse
ascites) and from mouse bone marrow cells were all
run alongside OX174 HaeIII standard fragments.
The enzyme digestion has produced banding
patterns, representative of digestion of the
chromatin into smaller molecular weights and
indicating the presence of nucleosomal monomers
(arrowed), dimers, trimers and larger oligomers.
Differences are apparent in the distances to which
the samples from different cellular origins have
migrated. DNA from cultured L1210 cells (b) has
migrated fastest and that from mouse bone marrow
(c) the slowest. Quantitative values, in terms of
length in base pairs (bp), were obtained by
averaging the differences between the first
(monomer) and next 4-6 bands. This method gives
a more accurate measurement of linker length than
using the values for the bands themselves as the
enzyme trims the cut ends of the polynucleosomes
during digestion (Noll & Kornberg, 1977). Table I
shows the repeat lengths for the three cell types
Figure 1 Electrophoresis of micrococcal nuclease-
digested DNA from nuclei isolated from cultured
L1210 cells (b), mouse bone marrow cells (c) and
L1210 ascites cells (d). (a)=OX174 marker DNA. The
arrow indicates the position of the nucleosomal
monomer fraction. A further, irrelevant lane has been
masked to fascilitate direct comparison of the
important samples.
Table I DNA repeat lengths measured using electro-
phoresis of micrococcal nuclease-digested chromatin from
mouse bone marrow and L1210 leukaemia cells. Values
indicate numbers of base pairs Linker length=repeat
length-146bp
Cell type
Expt. No Bone marrow L1210-Ascites L1210-Culture
1 197.9 192.8 181.9
2 213.9 196.0 196.2
3 210.0 203.3 190.2
4 210.1 196.0 187.5
5 210.7 202.0 181.2
6 209.2 193.9 181.5
Mean/sd 208.6/5.0 197.3/3.9 186.4/5.5
Linker length 62.6 51.3 40.4
derived from 6 separate experiments, involving up
to three measurements on each gel. It is apparent
that L1210 ascites and cultured L1210 cells differ
by the same amount as do bone marrow and L1210
ascites cells, that is by about 11 bp.380 S.W. DEAN et al.
Data published previously (Green et al., 1982)
showed the overall binding of CCNU and CLZ to
bone marrow and L1210 ascites chromatin, in
addition to the proportion of drug associated with
micrococcal nuclease sensitive DNA. Using these
values in conjunction with our own measurements
of linker length it is possible to obtain estimates of
drug binding to both linker and nucleosomal DNA,
(pmolmg- DNA). These values were then
converted to estimates of alkylations/105bp. These
figures are shown in Table II and clearly show that
more marrow-toxic CCNU binds to the
nucleosomal DNA in both cell types and less to the
linker DNA. CLZ, on the other hand, binds less to
the nucleosomal DNA of bone marrow, but causes
considerable alkylation of L1210 nucleosomal
DNA. Furthermore, CLZ shows more alkylation of
bone marrow, as compared with L1210, linker
DNA.
Table II Estimated binding of CCNU and CLZ to
linker and nucleosomal DNA in murine bone marrow
and L1210 leukaemia cells from mouse ascites fluid.
Numbers represent alkylations per 105 base pairs
Drug Cell type Linker Nucleosome
Bone marrow 2 22
CCNU
L1210 1 13
Bone marrow 11 16
CLZ
L1210 3 30
The banding patterns derived from electro-
phoresis of DNA from control and drug-treated, in
vitro L1210 cells are shown in Figures 2 and 3.
Treatment for 6h with 1 mM CCNU (Figure 2) has
no effect on micrococcal nuclease digestion, neither
has treatment for 1 h with 4mM CLZ or 1 mM L-
PAM, (Figure 3). HN2, on the other hand at 1 mM
for 1 h caused an increase in the proportion of
mononucleosomal and smaller oligomer fractions,
as well as a small reduction in the rate of
migration, (Figure 3).
Discussion
Consistent and reproducible differences have been
found in the repeat length of the DNA from bone
marrow and L1210 leukaemia cells from mouse
ascites. The bone marrow linker region (63bp) was
-22% longer than that in the tumour (51 bp).
Drug binding data shown in Table II suggests
that the toxicity of CLZ and, indeed, other chloro-
ethylnitrosoureas, is related to the extent to which
Figure 2 Electrophoresis of micrococcal nuclease-
digested DNA from nuclei isolated from cultured
L1210 cells, untreated (b) or after incubation for 6h
with 1 mM CCNU (c). (a)=OX174 marker DNA. The
arrow indicates the position of the nucleosomal
monomer fraction.
the drugs alkylate nucleosomal DNA. Reaction
with linker DNA is probably less critical as
evidenced by the binding of CLZ to bone marrow
linker DNA. This correlates with reports of
preferential repair of internucleosomal DNA
(Bodell, 1977; Cleaver, 1977; Smerdon et al., 1979)
which would render alkylation in this region less
cytotoxic. It is possible that variation in cellular
sensitivity to the different types of drug may be a
result of differences in the ability of cells to repair
drug-induced damage to linker versus nucleosomal
DNA.
The observed repeat lengths of cultured L1210
cells and those grown in vitro, 186+5 and
197+4bp respectively, are in approximate
accordance with a report that cells in culture
generally have a repeat length of less than 196bp
(Compton et al., 1976). It was also suggested that
increased repeat length may correspond to
increased cell growth and genetic activity. Murine
bone marrow consists of a variety of cell types,
varying in proliferative status from pluripotential
stem cells to mature blood cells (Tavassoli &
Yoffey, 1983) and it is estimated that only about 1
in 104 represent the colony forming units (Coggle
& Gordon, 1975), the great majority being matureDNA REPEAT LENGTH IN MURINE TUMOUR AND BONE MARROW 381
Figure 3 Electrophoresis of micrococcal nuclease-
digested DNA from nuclei isolated from cultured
L1210 cells, untreated (b) or after incubation for 1 hr
with 4mM CLZ (c), 1 mM HN2 (d) or 1 mM L-PAM
(e). (a) =OX174 marker DNA. The arrow indicates the
position of the nucleosomal monomer.
and hence non-dividing cells. Thus, not only have
we observed a consistent and reproducible
measurement of repeat length but we have seen a
longer repeat length in a population containing
a large proportion of non-dividing cells compared
to both L1210 populations which were maintained
in exponential growth.
It is also important to note that neither CCNU
nor CLZ had any measurable effect on the
digestion of L1210 DNA by micrococcal nuclease.
This observation serves to validate previous studies
which used micrococcal nuclease digestion of
nitrosourea-treated chromatin (Tew et al., 1978,
Green et al., 1982). The alteration of the digestion
pattern seen after treatment with HN2 would
advise caution if the site of binding of this drug
were to be investigated by following the micro-
coccal nuclease-induced release of HN2 from
treated chromatin.
In conclusion, a 22% longer DNA linker length
in murine bone marrow cannot account quanti-
tatively for the reported 2-4 fold increased binding
of sugar nitrosoureas to linker DNA (Green et al.,
1982). The effective specificity of sugar nitrosoureas
for tumour cells and their reduced myelotoxicity
may lie in other structural or conformational dif-
ferences in the chromatin and associated proteins
in these two cell types.
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